Fig. 6: Gelatinization studies in bone defect model.
From: X-ray-activated polymerization expanding the frontiers of deep-tissue hydrogel formation
a Schematic diagram of the model. Solution in injector contains polyethyleneglycoldiacrylate (PEGDA) (40%, m/v), complex of camphorquinone and methyl-β-cyclodextrin (MCD/CQ) (CQ: 3%, m/v), triethanolamine (6%, m/v), and halloysite nanotubes-based X-ray-activated visible persistent luminescent emitting phosphors (HNTs@YF3:Tb3+, 5%, m/v). b Sawed section of the bone defect model after irradiation. c The formed removable substance inside the bone. d The sawed section after removing the hydrogel. e Rheological property of the as-formed hydrogel. f Thickness test.
